(866) 389-4659
Resources Pregnancy Guide Understanding Your Screenings Planning Hospital Bag Checklist Birth Plan Template
Cord Blood 101 Why Stem Cells Matter What Is Cord Blood? What Is Cord Tissue? Public vs. Private Banking Treatment & Research Cellular Materials Clinical Research StemCyte Biologics
Start Here Build Your Plan FAQ Advanced Protection Public Bank Access HLA Matching Newborn Genetic Analysis MaxCell® LifeSaver Guarantee Community Programs Special Programs Refer a Friend Public Banking Expanded Access Program
Our Impact Track Record How We Compare Patient Stories Who We Are About StemCyte
Build Your Plan

MaxCell® is StemCyte's premium cord blood processing method that uses plasma depletion to preserve more total nucleated cells than conventional red-cell-depletion processing. MaxCell® stores the cord blood in a 100 mL volume, compared with 25 mL for StandardCell® processing, retaining a larger usable cell yield for future transplantation. MaxCell® is offered by StemCyte, Inc., a global cord blood bank founded in 1997 in Baldwin Park, California, accredited by FACT and AABB, and the U.S. licensee of REGENECYTE® under FDA US License 2280.

Small beginnings. <i>Maximum cells.</i>
Processing · MaxCell®

Small beginnings. Maximum cells.

MaxCell® preserves 100 mL of cord blood vs. ~25 mL standard. Four times the volume, more of the cells used in engraftment.

The difference

How does MaxCell® preserve more cells?

Most cord blood banks reduce a unit to a concentrate, stripping out cells in the process. MaxCell® is StemCyte's proprietary processing method, engineered to preserve a higher recovery of total nucleated cells, keeping more of the cord blood that was there at birth.

StandardCell
0 mL
Concentrated unit. Cells lost in processing.
MaxCell®
0 mL
Tempers less with the cord blood. More total nucleated cells preserved.

Why does MaxCell® processing matter?

More cells, better odds

Total nucleated cell (TNC) count is a key predictor of engraftment success. Research has shown that higher TNC doses are associated with faster engraftment and better survival outcomes in cord blood transplants. MaxCell® processing preserves more TNCs than standard red blood cell depletion methods.

More options, later

A larger preserved unit gives future physicians flexibility. Some emerging cord blood therapies benefit from having a higher cell count or volume than a concentrated 25mL unit can provide. Preserving closer to the full 100mL of the original sample keeps more treatment pathways available, including applications not yet available.

Frequently asked questions

MaxCell® is offered as a premium processing option on StemCyte storage plans. Final pricing depends on the plan you choose, see our Plans & Pricing page for details.
Plasma depletion is the technical category. MaxCell® is StemCyte's proprietary implementation of it. The point isn't the name, it's that MaxCell® tempers less with the cord blood, preserving more total nucleated cells for a higher potential transplant dose.
Standard processing concentrates a cord blood unit into a smaller storage volume, but cells are lost in the process. MaxCell® prioritizes cell preservation over volume reduction, you get a larger stored unit, with more of the original cord blood intact.
Yes. MaxCell®-processed cord blood units have been used in transplants worldwide.

Start with more.

Plans with MaxCell® processing preserve four times the volume of standard processing, for whatever treatment the future holds.

Build your plan